Amedisys (NASDAQ:AMED) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report released on Monday. The brokerage issued a buy rating on the health services provider’s stock. Several other equities analysts have also recently weighed in on AMED. TD Cowen increased their price target on Amedisys from $84.00 to $101.00 and gave […]
More Stories
Contrasting Seacoast Banking Co. of Florida (NASDAQ:SBCF) and John Marshall Bancorp (NASDAQ:JMSB)
John Marshall Bancorp (NASDAQ:JMSB – Get Free Report) and Seacoast Banking Co. of Florida (NASDAQ:SBCF – Get Free Report) are...
Spin Master Corp. (OTCMKTS:SNMSF) Announces $0.09 Dividend
Spin Master Corp. (OTCMKTS:SNMSF – Get Free Report) declared a dividend on Friday, December 20th,investing.com reports. Investors of record on...
Flexsteel Industries, Inc. (FLXS) To Go Ex-Dividend on December 27th
Flexsteel Industries, Inc. (NASDAQ:FLXS – Get Free Report) declared a quarterly dividend on Wednesday, December 11th,Wall Street Journal reports. Shareholders...
Canadian Imperial Bank of Commerce (CM) To Go Ex-Dividend on December 27th
Canadian Imperial Bank of Commerce (NYSE:CM – Get Free Report) (TSE:CM) announced a quarterly dividend on Friday, December 6th,Wall Street...
Sun Art Retail Group Limited (OTCMKTS:SURRY) Raises Dividend to $0.17 Per Share
Sun Art Retail Group Limited (OTCMKTS:SURRY – Get Free Report) declared a dividend on Wednesday, December 11th,NASDAQ Dividends reports. Investors...
Oklo (NYSE:OKLO) Shares Down 7.7% Following Insider Selling
Oklo Inc. (NYSE:OKLO – Get Free Report)’s stock price traded down 7.7% on Monday after an insider sold shares in...